Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | Executive Vice President, Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Salveen Richter | Goldman Sachs |
Biren Amin | Jefferies |
Matthew Holt | JPMorgan |
Marc Frahm | Cowen & Company |
Mark Breidenbach | Oppenheimer |
Alexander Duncan | Piper Sandler |
John Newman | Canaccord |
Michael Schmidt | Guggenheim |
Tony Butler | ROTH Capital Partners |
Asthika Goonewardene | SunTrust |
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Allogene Therapeutics First Quarter 2020 Conference Call. [Operator instructions] Please be aware that today’s conference call is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Ms.